BPC-157 is not FDA approved for any therapeutic indication as of April 2026
Research indicates it accelerates gastrointestinal transit and may ameliorate symptoms of postoperative ileus
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data
1897.R1) and with the IRB committee, Al Yousif Hospital, Alkhobar, Saudi Arabia, (AYH IRB: 02/03/2023)
Identity shifts during weight loss deserve attention
Managing Common Injection Site Reactions and When to Seek Help Mild reactions such as temporary redness, small bruises, or minor swelling typically resolve within 24 to 48 hours and do not require intervention